Active Stocks
Fri Jun 27 2025 15:59:58
  1. Tata Steel share price
  2. 161.40 0.56%
  1. Itc share price
  2. 418.95 -0.33%
  1. Tata Motors share price
  2. 686.70 0.54%
  1. Ntpc share price
  2. 337.95 0.24%
  1. State Bank Of India share price
  2. 805.40 1.05%
Business News/Market/Market Stats/    Lincoln Pharmaceuticals

LINCOLN PHARMACEUTICALS SUMMARY

Lincoln Pharmaceuticals is trading 1.15% upper at Rs 567.45 as compared to its last closing price. Lincoln Pharmaceuticals has been trading in the price range of 568.65 & 562.70. Lincoln Pharmaceuticals has given -28.33% in this year & 0.6% in the last 5 days.

 

Lincoln Pharmaceuticals has TTM P/E ratio 13.41 as compared to the sector P/E of 22.43. There are 1 analysts who have initiated coverage on Lincoln Pharmaceuticals. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 11.58 Crores in its last quarter.

 

Listed peers of Lincoln Pharmaceuticals include Bliss Gvs Pharma (5.54%), Hester Biosciences (2.82%), Lincoln Pharmaceuticals (1.15%) etc.

 

Lincoln Pharmaceuticals has a 49.78% promoter holding & 50.22% public holding.

FAQs about Lincoln Pharmaceuticals

Lincoln Pharmaceuticals is trading at 567.45 as on 27 Jun, 2025 3:28:00 PM. This is 1.15% upper as compared to its previous closing price of 561
The market capitalization of Lincoln Pharmaceuticals is 1134.57 Cr as on 27 Jun, 2025 3:28:00 PM.
The average broker rating on Lincoln Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 0.00 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 0.00 analysts have given a strong buy rating
The 52 wk high for Lincoln Pharmaceuticals is 975.00 whereas the 52 wk low is 500.00
Lincoln Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 13.41
  • Sector P/E: 22.43
  • Dividend Yield: 0.32%
  • D/E ratio: -
Lincoln Pharmaceuticals reported a net profit of 82.35 Cr in 2025.
Recommended For You